Showing results (321-330 of 4,868) with videos related to
Sort By:
Pageof 487
Urologic Oncology|August 17, 2021
Inguinal lymph node density as a powerful predictor of cancer specific survival in patients with node-positive penile cancerJulian Chavarriaga, Diego Camacho, Daniel Suso-Palau, et al.Urologic Oncology|September 21, 2021
Combination MRI-targeted and systematic prostate biopsy may overestimate gleason grade on final surgical pathology and impact risk stratificationAlice Yu, Tammer Yamany, Amirkasra Mojtahed, et al.Urologic Oncology|May 16, 2020
Incident testicular cancer in relation to using marijuana and smoking tobacco: A systematic review and meta-analysis of epidemiologic studiesAshley Song, No Kang Myung, David Bogumil, et al.Urologic Oncology|May 16, 2020
Trends in treatment of cT1 penile cancer: Analysis of the National Cancer DatabaseAllison May, Parth Joshi, Facundo Davaro, et al.Urologic Oncology|May 16, 2020
Testosterone replacement therapy (TRT) and prostate cancer: An updated systematic review with a focus on previous or active localized prostate cancerLouis Lenfant, Priscilla Leon, Géraldine Cancel-Tassin, et al.Urologic Oncology|May 12, 2020
A nomogram incorporating PD-L1, NLR, and clinicopathologic features to predict inguinal lymph node metastasis in penile squamous cell carcinomaJiao Hu, Huihuang Li, Tongchen He, et al.Urologic Oncology|April 9, 2020
The effect of multiplicity of PI-RADS 3 lesions on cancer detection rate of confirmatory targeted biopsy in patients diagnosed with prostate cancer and managed with active surveillanceGrace Yaguchi, Hoang J Tang, Mustafa Deebajah, et al.Urologic Oncology|May 21, 2020
The contrasting roles of Dysferlin during tumor progression in renal cell carcinomaAlexander Cox, Chenming Zhao, Yuri Tolkach, et al.Urologic Oncology|June 25, 2020
D2-40/podoplanin expression in cancer stroma by immunohistochemical staining is associated with poor prognosis in bladder cancer patients after radical cystectomyEijiro Okajima, Mitsuru Tomizawa, Keiji Shimada, et al.Urologic Oncology|May 3, 2021
A 25-year perspective on advances in the study of the epidemiology, disparities, and outcomes of urologic cancersSarah P Psutka, Eric A Singer, John GorePageof 487